02325.HK
Yunkang Group Limited
HKSE · Healthcare · Medical - Diagnostics & Research · CN
HKD 0.62
−3.88%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 55.60x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 5.33x
- PEG TTM
- —
- Price / book
- 0.27x
- Price / sales
- 0.57x
- Price / cash flow
- —
Enterprise value
- Enterprise value
- -HKD 747.3M
- EV / sales
- -1.17x
- EV / EBITDA
- -4.34x
- EV / EBIT
- -7.39x
- Market cap
- HKD 362.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026